Last update:

Weight management news

Is poor sleep contributing to the country's weight issues?

Some 70% of teens trying to adapt to a fall schedule are missing out on sleep. Early bells and tough classes combine with delayed biological clocks during adolescence, keeping their nightly sleep duration during the school ...

GLP-1 use among young children with obesity in US remains rare but is rising rapidly

Although the number of U.S. children under age 12 with obesity who are prescribed the weight-loss drugs Saxenda, Wegovy and Zepbound remains low, it was 310 times higher in June 2026 than in 2019, when the drugs were first ...

Some hair loss in men is linked to weight loss drug use

Men already genetically at risk for the most common form of hair loss have a 7% added risk of losing their hair if they use drugs like Ozempic, Wegovy and Zepbound for type 2 diabetes and obesity, a new study shows.

Why men can struggle with weight-loss initiatives

A new study has identified why many men struggle with weight loss, finding that traditional diet programs are often perceived as too restrictive and primarily aimed at women. The research, published in PLOS One and led by ...

GLP-1 meds prompt rethink of obesity and eating disorder care

Obesity and eating disorders have traditionally been treated as separate areas of health care—but the rapid rise of GLP-1 medicines is increasingly bringing the two together. Adelaide University researchers say the growing ...

Unexpected brain mechanism challenges assumptions about GLP-1s

For decades, obesity medications produced only modest weight loss. But in recent years, Ozempic and related GLP-1 therapies have transformed the field, enabling sustained weight loss of 10% to 15% or more. Despite their success, ...